Key result
Pregnant women with pulmonary artery hypertension had a maternal mortality of and lower rates of heart failure compared to those with Eisenmenger syndrome.
Why the study?
Maternal-fetal morbidity and mortality in pregnant women with pulmonary artery hypertension and Eisenmenger syndrome are unacceptable, and management decision-making remains debatable.
What are the maternal and fetal outcomes in pregnant women with Eisenmenger syndrome compared to those with pulmonary artery hypertension?
Cohort (n=50)
No
What are the maternal and fetal outcomes in pregnant women with Eisenmenger syndrome compared to those with pulmonary artery hypertension?
Fetomaternal outcomes are significantly worse in pregnant women with Eisenmenger syndrome compared to those with pulmonary artery hypertension, particularly regarding heart failure and hypoxemia.
Answers are grounded in this paper and cite their sources.
Supports differential risk stratification by PAH subtype in pregnancy; leaves open mortality impact and requires prospective confirmation.
OBJECTIVES: Maternal-fetal morbidity and mortality among pregnant women with pulmonary artery hypertension (PAH) and Eisenmenger syndrome are unacceptable, and management decision-making in these clinical scenarios remains debatable. This study aimed to compare and analyse clinical characteristics, management and pregnancy outcomes in PAH and Eisenmenger syndrome. DESIGN: Prospective observational cohort study. SETTINGS: A large tertiary care university hospital. PATIENTS: Thirty patients with pulmonary artery hypertension and 20 patients with Eisenmenger syndrome. METHODS: Data pertaining to clinical characteristics, anaesthetic, medical and obstetric management, and outcomes in pregnancy complicated by PAH and Eisenmenger syndrome were collected between July 2020 and June 2022. Each treating unit followed its management protocol in consultation with the multidisciplinary team. MAIN OUTCOME MEASURES: Maternal mortality and morbidity. RESULTS: Maternal mortality was lower in the PAH group (6.6% versus 15%; p = 0.33). All mortalities were in the postpartum period. The incidence of new-onset or exacerbation of heart failure (23.3% versus 60%; p = 0.009) and hypoxaemia (13.3% versus 50%; p = 0.005) were significantly lower in the PAH group. In the Eisenmenger syndrome group, a significantly higher number of women received pulmonary hypertension and heart failure medications. Prematurity and neonatal intensive care unit admission were frequently noticed in Eisenmenger syndrome, whereas perinatal mortality, birthweight and APGAR score were comparable. CONCLUSIONS: Fetomaternal outcomes are inferior in Eisenmenger syndrome compared with PAH and are either lower or comparable to those reported from contemporary cohorts of developed nations.
No takes yet. Share an insight, caveat, or question.
Jha et al. (2023) conducted a cohort in Pulmonary artery hypertension and Eisenmenger syndrome during pregnancy (n=50). Pulmonary artery hypertension vs. Eisenmenger syndrome was evaluated on Maternal mortality (p=0.33). Pregnant women with pulmonary artery hypertension had a maternal mortality of and lower rates of heart failure compared to those with Eisenmenger syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: